← SynDRA
BEXAGLIFLOZIN
SynDRA canonical compound SYN0027491 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SLC5A2 |
|---|
| Mechanism of action | solute carrier family member inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- SLC5A2 INHIBITOR
- Sodium/glucose cotransporter 2 inhibitor
- solute carrier family member inhibitor
Drug classes
- Hypoglycemic Agents
- Sodium-Glucose Transporter 2 Inhibitors
- Sodium-Glucose Cotransporter 2 Inhibitor
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- brenzavvy
- EGT0001442
- EGT1442
- THR1442
- THR-1442
- Bexagliflozine
- Bexagliflozina
- Brenzavvy
- EGT-0001442
- EGT-1442
- UNII-EY00JF42FV
- Bexagliflozin [USAN]
- EY00JF42FV
- CHEMBL1808388
- Bexagliflozin (USAN)
- D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(2-(cyclopropyloxy)ethoxy)phenyl)methyl)phenyl)-, (1S)-
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-D-glucitol
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropylo
- BRENZAVVY
- EGT 1442
- THR 1442
- bexagliflozina
- bexagliflozine
- bexagliflozinum
- Bexacat
- bexagliflozin tablets
- RefChem:57074
- MFCD28100944
- Bexagliflozin3
- Brenzavvy (TN)
- Bexgliflozin Impurity 1
- EGT1442; Bexagliflozin
- BEXAGLIFLOZIN [INN]
- Bexgliflozin (EGT1442)
- Bexagliflozin (EGT1442)
- C24H29ClO7
- SCHEMBL302200
Look up BEXAGLIFLOZIN in the interactive SynDRA portal →